Funder: National Institutes of Health

Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | May 7, 2026 (AIDS) | June 16, 2026 (New) | July 16, 2026 (Renewal/Resubmission/Revision) | September 7, 2026 (AIDS) | October 16, 2026 (New) | November 16, 2026 (Renewal/Resubmission/Revision) | January 7, 2027 (AIDS)

Funding Amounts: Up to $450,000 direct costs over 3 years; no more than $225,000 direct costs in any single year; maximum project period is 3 years.

Summary: Supports pilot studies essential for planning Phase II-IV clinical trials on heart, lung, blood, and sleep disorders within NHLBI’s mission.

Key Information: Updated March 2025; applications must include a 3-page future clinical trial description and comply with new NIH Data Management and Sharing requirements.